Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
112.45
+2.77 (2.53%)
At close: Sep 18, 2026, 4:00 PM EDT
112.61
+0.16 (0.14%)
Pre-market: Sep 21, 2026, 7:15 AM EDT
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $115 | Buy | Reiterates | $115 | +2.27% | Sep 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 → $105 | Buy | Reiterates | $93 → $105 | -6.63% | Aug 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $83 → $110 | Buy | Upgrades | $83 → $110 | -2.18% | Aug 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | -17.30% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $75 → $95 | Hold | Reiterates | $75 → $95 | -15.52% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $96 → $105 | Buy | Reiterates | $96 → $105 | -6.63% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $57 | Sell | Maintains | $57 | -49.31% | Jun 15, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains $70 | Hold | Maintains | $70 | -37.75% | May 20, 2026 |